183. Breast J. 2018 Jul;24(4):676-677. doi: 10.1111/tbj.13027. Epub 2018 Mar 8.A breast multi-disciplinary genomic tumor board is feasible and can providetimely and impactful recommendations.Tsung K(1), Thompson CL(2)(3), Knight JM(3), Maximuk S(1), Sadri N(1), GilmoreH(1)(3), Keri RA(3)(4)(5), Vinayak S(1)(3), Harris L(6), Silverman P(1)(3).Author information: (1)University Hospitals Seidman Cancer Center, Cleveland, OH, USA.(2)Department of Nutrition, Case Western Reserve University, Cleveland, OH, USA.(3)Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA.(4)Department of Pharmacology, Case Western Reserve University, Cleveland, OH,USA.(5)Department of Genetics and Genome Sciences, Case Western Reserve University,Cleveland, OH, USA.(6)National Cancer Institute, Bethesda, MD, USA.DOI: 10.1111/tbj.13027 PMID: 29517142 